D Green 🇺🇲🇸🇯

[D Green 🇺🇲🇸🇯 @dngreenwold]

@ma_pete13 @Brewers Even if you have to give up Henderson for Skubal, they still could have gotten May or another guy as their 4th SP. Plus maybe Frias slots right into top 3-5 prospects by 2027 to replace Pena if he goes to DET. And not to get at least one bat is ridiculous. Grade: D-

[D Green 🇺🇲🇸🇯 @dngreenwold]

cc: @ma_pete13

[Adam McCalvy @AdamMcCalvy]

Alexander Frias and Josiah Ragsdale are going to St. Louis in the trade, per source.

[D Green 🇺🇲🇸🇯 @dngreenwold]

@s_a_s_55 If Logan Henderson is the reason the Brewers didn't get Skubal, I'm not okay with that...and he's not exactly the beacon of health.

[D Green 🇺🇲🇸🇯 @dngreenwold]

Death, taxes, and #brewers fans overvaluing prospects for "just a rental"

[D Green 🇺🇲🇸🇯 @dngreenwold]

@ma_pete13 Dodgers gave up their third best OF prospect on that particular minor league team alone, a 28 year old pitcher with an injury history, and another pitcher with an ERA over 7.00 in A-ball for a ring chaser who couldn't get it done as the club leader last year.

[D Green 🇺🇲🇸🇯 @dngreenwold]

@ma_pete13 Absolutely. So many ridiculous #brewers fans replies on these trade rumor posts. Stop the prospect hugging, people. Can Brewers finally try to go for it? Trade for Skub, then get some LHP bullpen help and 1 or 2 stud hitters. Very, very few prospects should be off limits.

[D Green 🇺🇲🇸🇯 @dngreenwold]

@ma_pete13 No prospect should be off limits other than Made. And even Made should be on the table if an absolute stud with 3+ years of control becomes available (i.e. Elly). We're going to replenish the farm system when (unfortunately) Contreras and Turang get dealt. GO ALL IN.

[Matt Maddock @matthewmaddock]

The Canadian environmental police are pumping out 200 tons of carbon an hour today. More than the entire USA does every five years.

[Gizmo Memes @GizmoMemes]

Mitch McConnell showing up to vote against the SAVE America Act 😭

[D Green 🇺🇲🇸🇯 @dngreenwold]

@ma_pete13 At the game tonight?

[Dave Portnoy @stoolpresidente]

Very cool. Point for college baseball.

[Spencer Pratt @spencerpratt]

Now this is a story all about how my life got flipped, turned upside down

[Baseball America @BaseballAmerica]

Welcome to the Top 100, Josh Adamczewski.

The @BrewersPD got another one ⤵️

https://t.co/AhNarjQoya

[Nicolas Hulscher, MPH @NicHulscher]

🚨BREAKING: Largest Real-World Study of Ivermectin + Mebendazole in Cancer Patients Shows 84.4% Clinical Benefit — Nearly HALF Report Cancer Disappearance or Tumor Regression

After just 6 months, 48.4% of cancer patients taking ivermectin and mebendazole reported NO EVIDENCE OF DISEASE (32.8%) or tumor regression (15.6%), while 36.1% reported disease stabilization⬇️

We have completed the largest real-world human analysis to date evaluating ivermectin and mebendazole in cancer patients—and the results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

The groundbreaking analysis was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel (Dr. Harvey Risch)—uniting real-world clinical data, frontline medical experience, and high-level epidemiologic expertise to deliver urgently needed insights in oncology.

This was a real-world prospective clinical program evaluation of 197 cancer patients, with 122 completing a follow-up survey at about six months (61.9% response rate).

Cancer patients were prescribed compounded ivermectin–mebendazole, with each capsule containing 25 mg ivermectin and 250 mg mebendazole—most commonly taken at 1–2 capsules per day.

The cohort represented a clinically relevant population, including a wide variety cancer types, with 37.1% of patients reporting actively progressing disease at baseline and many having already undergone chemotherapy, radiation, and surgery.

At six months, 84.4% of cancer patients reported clinical benefit (Clinical Benefit Ratio: 84.4% [95% CI: 77.0–89.8%]):

✅ 32.8% reported no evidence of disease (95% CI: 25.1–41.5%)
✅ 15.6% reported tumor regression (95% CI: 10.2–23.0%)
✅ 36.1% reported stable disease (95% CI: 28.1–44.9%)

Treatment adherence was high, with 86.9% completing the full protocol and 66.4% remaining on therapy at six months.

The regimen was well tolerated, with 25.4% reporting side effects, primarily mild and gastrointestinal, and over 93% continuing treatment despite these events.

Patients were treated in real-world conditions alongside concurrent therapies, including chemotherapy (27.9%), radiation (21.3%), surgery (19.7%), supplements (49.2%), and dietary modification (37.7%), supporting use as an adjunctive approach.

Together, these findings represent a large, internally consistent real-world clinical signal that supports URGENT further investigation of ivermectin and mebendazole as low-toxicity, adjunctive cancer therapies.

Given the strength of the signal observed here, advancing this line of investigation is no longer optional—it is necessary.

This is NOT the end. We will continue advancing this work with larger datasets to further define and validate the role of anti-parasitics in cancer outcomes.

The manuscript is now available as a preprint on the Zenodo research repository, operated by the European Organization for Nuclear Research, while undergoing peer review at leading oncology journals: “Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort.”

@twc_health @McCulloughFund @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

[D Green 🇺🇲🇸🇯 @dngreenwold]

@MyaLover

[Travis Wilson @TravisBOUND]

D1 state champions Arrowhead. #wisgb

[Big Ten Network @BigTenNetwork]

Come for the adorable vintage home video of Isaac Gard 🤗

Stay for Isaac and dad Greg Gard reminiscing about their time together with @BadgerMBB 🥹

The Journey takes you behind the scenes with the Gards.

[Scott Walker @ScottWalker]

It was great to talk with students at Arrowhead High School for @yaf

[Bussin' With The Boys @BussinWTB]

Team USA in the locker room singing Toby Keith with the FBI Director...

What a world